Claro Advisors’s Boston Scientific BSX Stock Holding History

Claro Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$203K	Sell	3,229 -619	-16%	-$49.5K	0.02%	489
2025 Q4	$367K	Buy	+3,848	New	+$377K	0.05%	281
2025 Q3	–	Sell	-2,147	Closed	-$231K	–	403
2025 Q2	$231K	Sell	2,147 -427	-17%	-$43.2K	0.04%	340
2025 Q1	$260K	Sell	2,574 -161	-6%	-$16.2K	0.03%	427
2024 Q4	$244K	Buy	+2,735	New	+$241K	0.03%	411
2024 Q3	–	Sell	-2,612	Closed	-$201K	–	516
2024 Q2	$201K	Buy	+2,612	New	+$191K	0.03%	410
2019 Q1	–	Sell	-359	Closed	-$14K	–	254
2018 Q4	$14K	Buy	+359	New	+$13K	0.01%	609

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Claro Advisors's BSX Position: Q1 2026 in Review

Claro Advisors reduced its Boston Scientific (BSX) stake by 16% in Q1 2026, selling an estimated $49.5K and leaving 3,229 shares worth $203K. The position accounts for 0.02% of the portfolio, ranked #489.

Claro Advisors first reported a position in BSX in Q4 2018 and has held it in 7 quarters since. The position peaked at $367K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Claro Advisors held 3,229 shares of Boston Scientific worth $203K as of Q1 2026.
Claro Advisors sold 619 Boston Scientific shares in Q1 2026, an estimated $49.5K.
Boston Scientific made up 0.02% of Claro Advisors's portfolio in Q1 2026, its #489 holding.
Claro Advisors first reported a position in Boston Scientific in Q4 2018 and has held it in 7 quarters since.
Claro Advisors's Boston Scientific position peaked at $367K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.